Showing results (11-20 of 19) with videos related to
Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 19 results.
Cancer Immunology, Immunotherapy : CII|May 2, 2021
CD38 identifies pre-activated CD8+ T cells which can be reinvigorated by anti-PD-1 blockade in human lung cancerPin Wu, Lufeng Zhao, Yongyuan Chen, et al.Cancer Letters|April 3, 2024
JAML promotes the antitumor role of tumor-resident CD8+ T cells by facilitating their innate-like function in human lung cancerZhixing Hao, Zhongwei Xin, Yongyuan Chen, et al.Nature Communications|September 17, 2022
The immune landscape of human thymic epithelial tumorsZhongwei Xin, Mingjie Lin, Zhixing Hao, et al.European Journal of Immunology|October 7, 2022
Tissue-resident CD69+ CXCR6+ Natural Killer cells with exhausted phenotype accumulate in human non-small cell lung cancerXiaoke Chen, Yongyuan Chen, Zhongwei Xin, et al.Oncoimmunology|July 8, 2022
Oncolytic adenovirus promotes vascular normalization and nonclassical tertiary lymphoid structure formation through STING-mediated DC activationTeng He, Zhixing Hao, Mingjie Lin, et al.Cell Reports|February 14, 2024
Inflammatory dendritic cells restrain CD11b+CD4+ CTLs via CD200R in human NSCLCMingjie Lin, Di Chen, Zheyu Shao, et al.Frontiers in Immunology|February 4, 2022
Systemic Immune Dysregulation Correlates With Clinical Features of Early Non-Small Cell Lung CancerZhixing Hao, Mingjie Lin, Feng Du, et al.Journal for Immunotherapy of Cancer|August 12, 2024
Epithelium/imcDC2 axis facilitates the resistance of neoadjuvant anti-PD-1 in human NSCLCYongyuan Chen, Zheyu Shao, Zhixing Hao, et al.Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|January 4, 2026
PD-1 Inhibits CD4+ TRM-Mediated cDC1 Mobilization via Suppressing JAML in Human NSCLCZheyu Shao, Qinyuan Liu, Zhongwei Xin, et al.Pageof 2